News and media
Read our latest news, see departmental media and ministerial releases, and learn how you can have your say.
Departmental media enquiries
Contact for members of the media
Primary tabs
From 1 January 2016, notifications of medical contraindications and natural immunity will NOT be accepted on practice/GP letterhead.
Meningococcal B vaccine and clinical advice for immunisation providers regarding the use of Bexsero® (4CMenB). From 5 March 2014, the recombinant multicomponent meningococcal B vaccine Bexsero® (4CMenB) became available through purchase on the private market.
The Pertussis Chapter, 4.12, of the 10th Edition of the Australian Immunisation Handbook has been updated and includes two changes to recommendations in the administration of pertussis-containing vaccine.
Australian Technical Advisory Group on Immunisation (ATAGI) clinical advice to support the introduction of Rotarix® to replace RotaTeq® in specified Australian states (Western Australia, South Australia, Victoria and Queensland) from 1 July 2017.
The Australian Government launched the 'Get the facts about immunisation' campaign in August 2017 to encourage Australian parents and carers to get their kids vaccinated.
Australia's medicine and medical devices regulator, the Therapeutic Goods Administration (TGA), has decided to remove a number of mesh products whose sole use is the treatment of pelvic organ prolapse via transvaginal implantation from the Australian Register of Therapeutic Goods (ARTG).
Australia’s medicine and medical devices regulator, the TGA, has decided to remove a number of mesh products whose sole use is the treatment of pelvic organ prolapse via transvaginal implantation from the Australian Register of Therapeutic Goods (ARTG).
An Expert Health Panel has been established to advise the Australian Government on the potential health impacts associated with per- and poly-fluoroalkyl substances (PFAS) exposure and to identify priority areas for further research.
Media statement from Australia's Chief Medical Officer, Professor Brendan Murphy regarding media claims about flu vaccines.
The Australian Government is committed to immunisation and to ensuring Australia has the best possible vaccination program underpinned by sound evidence and effective vaccines.
The public and stakeholders now have an additional two weeks to provide input on the national Health Star Rating (HSR) system, as public consultation is extended until 17 August.
Following a decision by the European Commission to implement a number of medical device reforms, including to up-classify all surgical mesh medical devices to Class III and to provide patient implant cards and consumer product information for all implantable medical devices.
All Australian Governments have agreed to initiate the third review of the National Scheme for the Regulation of Gene Technology (the Review). The Review will be led by a working group comprised of senior officials from Commonwealth and state and territory governments.
Pharmaceutical company Novo Nordisk A/S, in consultation with the TGA, has initiated a consumer level recall of some batches of their NovoPen Echo insulin cartridge holder after detecting there is a possibility they may crack or break if exposed to chemicals in certain cleaning agents.
Australia’s therapeutic goods regulator is implementing new arrangements to simplify and improve the handling of complaints about the advertising of medicines and medical devices to the public.
Aboriginal and Torres Strait Islander children will be able to receive the seasonal influenza vaccine for free under the National Immunisation Program from 2015.
A national immunisation coverage target provides a goal against which Australia can measure its immunisation coverage. The Global Vaccine Action Plan 2011-2020 encourages countries to demonstrate a commitment to immunisation.
An additional 800,000 influenza vaccines secured for the National Immunisation Program.
A statement from the Chief Medical Officer about Listeria.
Media statement from Australia's Chief Medical Officer, Professor Brendan Murphy regarding media claims about flu vaccines.
Two cases of multi-drug resistant gonorrhoea have been recently detected in Australia. One case was diagnosed in Western Australia and a second case diagnosed in Queensland.
The Community should be reassured that our drinking water is safe.
A statement from the Acting Chief Medical Officer about bushfire smoke.
Read the transcript of Deputy Chief Medical Officer Professor Paul Kelly's press conference about coronavirus (COVID-19).
A media release from the Victorian Aged Care Response Centre giving an update on how it is working to protect senior Australians from COVID-19.
Health portfolio news and events
For news and events from our portfolio agencies, go to Our portfolio for links to their websites.